Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

23.82
Delayed Data
As of 3:59pm ET
 +0.11 / +0.46%
Today’s Change
16.75
Today|||52-Week Range
43.08
-27.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues14.4M48.4M13.0M14.0M
 
 
 
 
 
Depreciation And Amortization204.0K339.0K433.0K434.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.5M12.5M13.1M14.6M
 
 
 
 
 
Research And Development7.0M9.0M9.1M10.8M
 
 
 
 
 
Total Operating Expenses10.7M12.9M13.6M15.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.7M35.6M-565.0K-1.1M
 
 
 
 
 
Extraordinary Credit203.0K0.0075.0K0.00
 
 
 
Extraordinary Charge0.00-15.0K0.00-16.0K
 
 
 
Interest Expense On Debt2.0K12.0K11.0K11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.2M35.9M-93.0K-642.0K
 
 
 
 
 
Income Taxes-1.6M-9.7M-1.6M-434.0K
 
 
 
 
 
Net Income5.8M26.2M-1.6M-1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.7M18.8M18.9M19.0M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M19.3M18.9M19.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.29$1.36-$0.09-$0.06
 
 
 
 
 
EPS Diluted$0.29$1.36-$0.09-$0.06